State-Specific Prevalence of Adult Tobacco Product Use and Cigarette Smoking Cessation Behaviors, United States, 2018–2019
Preventing Chronic Disease · 2023
DOI: 10.5888/pcd20.230132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Preventing Chronic Disease, 2023. Verfasst von Monica E Cornelius und 6 weiteren Autor:innen. Beteiligte Einrichtung: Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 B…. Hauptthemen laut MEDLINE: Smoking Cessation, Electronic Nicotine Delivery Systems, Tobacco Use Disorder, Tobacco Products. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Increasing quitting among people who smoke cigarettes is the quickest approach to reducing tobacco-related disease and death.
Methods
We analyzed data from the 2018-2019 Tobacco Use Supplement to the Current Population Survey for 137,471 adult self-respondents from all 50 US states and the District of Columbia to estimate state-specific prevalence of current tobacco product use, interest in quitting smoking, past-year quit attempts, recent successful cessation (past-year quit lasting ≥6 months), receipt of advice to quit smoking from a medical doctor, and use of cessation medications and/or counseling to quit.
Results
Prevalence of current any-tobacco use (use every day or some days) ranged from 10.2% in California to 29.0% in West Virginia. The percentage of adults who currently smoked cigarettes and were interested in quitting ranged from 68.2% in Alabama to 87.5% in Connecticut; made a past-year quit attempt ranged from 44.1% in Tennessee to 62.8% in Rhode Island; reported recent successful cessation ranged from 4.6% in West Virginia and Wisconsin to 10.8% in South Dakota; received advice to quit from a medical doctor ranged from 63.3% in Colorado to 86.9% in Rhode Island; and used medications and/or counseling to quit ranged from 25.5% in Nevada to 50.1% in Massachusetts. Several states with the highest cigarette smoking prevalence reported the lowest prevalence of interest in quitting, quit attempts, receipt of advice to quit, and use of counseling and/or medication, and the highest prevalence of e-cigarette, smokeless tobacco, and cigar use.
Conclusion
Adults who smoke struggle with smoking cessation and could benefit from additional intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Hwy, Mailstop S107-7, Atlanta, GA 30341 (yex8@cdc.gov).
- Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
- Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
- Center for Tobacco Products, US Food and Drug Administration, Silver Spring, Maryland.
Zitieren
APA
Cornelius, M. E., Wang, T. W., Jamal, A., Loretan, C. G., Willis, G., Graham-Glover, B., & Neff, L. (2023). State-Specific Prevalence of Adult Tobacco Product Use and Cigarette Smoking Cessation Behaviors, United States, 2018–2019. Preventing Chronic Disease. https://doi.org/10.5888/pcd20.230132
Vancouver
Cornelius ME, Wang TW, Jamal A, Loretan CG, Willis G, Graham-Glover B, et al. State-Specific Prevalence of Adult Tobacco Product Use and Cigarette Smoking Cessation Behaviors, United States, 2018–2019. Preventing Chronic Disease. 2023. doi:10.5888/pcd20.230132
BibTeX
@article{Cornelius2023,
author = {Cornelius, Monica E and Wang, Teresa W and Jamal, Ahmed and Loretan, Caitlin G and Willis, Gordon and Graham-Glover, Bria and Neff, Linda},
title = {State-Specific Prevalence of Adult Tobacco Product Use and Cigarette Smoking Cessation Behaviors, United States, 2018–2019},
journal = {Preventing Chronic Disease},
year = {2023},
doi = {10.5888/pcd20.230132}
}
EUVIMED